Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 1Immunoblastic Lymphadenopathy 1

Interventions

Etoposide 3Cyclophosphamide 3romidepsin 2pembrolizumab 2Prednisone 2Doxorubicin 2prednylidene 1fludarabine phosphate 1etoposide phosphate 1deltacortene 1Whole-Body Irradiation 1Vincristine 1Valganciclovir 1Therapeutics 1Tacrolimus 1Sirolimus 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Lactones 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Depsipeptides 1Cyclosporine 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Immunoblastic Lymphadenopathy × Clinical Trials, Phase I as Topic × Clear all
NCT02223208 2025-12-02

FIL_PTCL13

Fondazione Italiana Linfomi - ETS

Phase 1/2 Active not recruiting
89 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡